Rocky Mountain Cancer Center - Denver — Denver, Colorado

Rocky Mountain Cancer Center - Denver is a clinical research site located in Denver, Colorado, United States 80220.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Center - Denver has participated in 8 clinical trials with 2 currently active.

Therapeutic areas: Neoplasm Metastasis, Non-Small Cell Lung Cancer, Breast Cancer.

Sponsors: Genentech, Inc., Hoffmann-La Roche, Biotheranostics, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Center - Denver?

Rocky Mountain Cancer Center - Denver has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Center - Denver conducted?

Rocky Mountain Cancer Center - Denver has 8 clinical trials on record, with 2 currently active. Their work covers Neoplasm Metastasis, Non-Small Cell Lung Cancer, Breast Cancer.

Is Rocky Mountain Cancer Center - Denver accredited by Crixeo Health?

Yes — Rocky Mountain Cancer Center - Denver holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rocky Mountain Cancer Center - Denver?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.